Once a stigmatized disease, AIDS is now a primary focus for many researchers seeking to address deadly health problems and potentially save the lives of millions of men, women and children. AIDS killed 1.5 million people worldwide last year, a staggering number that has drawn the attention of the Bill & Melinda Gates Foundation. Addressing this disease is a priority for the Gates Foundation, as is evidenced by all the work they have done to select and fund promising research. Fortunately, scientists all over the world are searching for innovative solutions to curing this disease. The Gates Foundation has found one likely contender for a vaccine that may also work as a cure in the work of a science researcher at Oregon Health and Science University.
Oregon Health and Science University along with two other public Oregon schools recently opened a new life sciences building, the state’s largest academic building, on Portland’s South Waterfront. The project received $110 million in life science funding from taxpayers, $92 million in funding from Oregon Health and Science University institutional funding, $83 million from OHSU philanthropy and $10 million from the TriMet regional mass transit agency. The riverfront property for the new research building was donated by the Schnitzer family to help OHSU increase its campus presence in Portland.
This month the Knight Cancer Institute at Oregon Health and Science University (OHSU) received a $10 million gift from Columbia Sportswear President and Chief Executive Officer Tim Boyle to recruit and support the next generation of cancer researchers.
Each year, Biotechnology Calendar, Inc. hosts over 55 BioResearch Product Faire™ events and 4 Biotechnology Vendor Showcase™ events all across the US. Of these shows, we have three BioResearch Product Faire™ Events in the state of Oregon: on the campuses of the University of Oregon, Oregon State University, and the Oregon Health and Science University.
Tags: 2014, 2013, Oregon State University, Oregon Health and Science University, UOr, Northwest, University of Oregon, Oregon, BioResearch Product Faire Event, Life Sciences, Front Line event, Front Line, Corvallis, Eugene, OHSU, Portland, Bioresearch Equipment, ORSTU
When taking into account a new grant to Oregon Health and Science University and recent NIH and NSF research funding, Oregon Health and Science University is a great market for lab suppliers marketing life science solutions and hoping to generate laboratory sales leads. Oregon Health and Science University was recently awarded $50 thousand in research funding by the National Psoriasis Foundation.
The National Eye Institute, an NIH agency dedicated to vision research, recently announced the winners of their Challenge to Identify Audacious Goals in Vision Research and Blindness Rehabilitation, or the Audacious Goals Challenge for short. The competition was open to professionals and members of the public and called upon them to think big and bold about vision research goals for the next decades. The prize money was nominal ($3,000) but included an invitation and travel money to attend and present their ideas at the NEI Audacious Goals Development Meeting in Maryland later this month. The real prize, of course, was the opportunity to help set research and funding goals for the next 10-12 years. Of the 500 or so proposals submitted, 10 visionaries were selected as winners.
Tags: University of Michigan, 2014, CA, Harvard University, Midwest, 2013, Northeast, university of utah, Washington University, Missouri, WashU, UUtah, St. Louis Bioresearch Product Faire Event, Oregon Health and Science University, Northwest, crowdsourcing, Vision Sciences Research, National Eye Institute (NEI), Blindness Rehabilitation, Southwest, University of Alabama, Southern, UT, Ann Arbor, Boston, BioResearch Product Faire Event, Funding, MI, MA, NIH, Harvard, OR, Salt Lake City, Birmingham, AL, UCSB, Santa Barbara, OHSU, Portland, UMich, UC Santa Barbara, Rehabilitation
The Knight Cancer Institute at Oregon Health & Science University (OHSU) in Portland has just announced an important partnership with San Diego-based bioprinting technology company Organovo. Research into the biology of cancer, especially how it metastasizes, has been complicated in the past by the limitations of animal models and cell cultures, which really don't tell us enough about the workings of cancer within a human being. Organovo creates living, 3-D human tissue using their bioprinting device, the NovoGen MMX (below). The partnership between OHSU and Organovo will allow cancer research at Knight Institute labs to much more closely model the complex architecture of malignancy within the human body, using in vitro tissue. Ultimately this will lead to the development of more accurate therapeutics and pre-clinical trials.
Tags: 2014, 2013, Oregon Health Sciences University, Oregon Health and Science University, Northwest, cancer research, Oregon, Cancer Treatment, bioprinting, BioResearch Product Faire Event, Funding, Front Line event, OR, OHSU, Portland, Northwest Region